Labshake search
Citations for BioLegend :
1 - 50 of 2868 citations for Recombinant Human X Linked Inhibitor of Apoptosis AVI tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: His-tagged recombinant soluble CD40L (sCD40L, BioLegend) was incubated with NTA-SUV or plain SUV ...
-
bioRxiv - Bioengineering 2024Quote: ... Recombinant human FcγIIa (Biolegend), FcγRIIb (Biolegend) ...
-
bioRxiv - Immunology 2024Quote: ... recombinant human CD40L (TNFSF5; BioLegend) was added to the media ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human IL-12p70 and recombinant human IL-18 at 10ng/ml (Biolegend; San Diego, CA).
-
bioRxiv - Bioengineering 2020Quote: ... recombinant human IL-15 (570308, Biolegend), recombinant mouse scIL-12 (130-096 ...
-
bioRxiv - Immunology 2022Quote: ... and recombinant human TPO (763706; Biolegend) for HSC culture conditions and 10 ng/mL of SCF ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human IL-15 (570308, Biolegend), recombinant mouse scIL-12 (130-096 ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant human interferon gamma (IFNγ; Biolegend) and recombinant human transforming growth factor beta-1 (TGF-β1 ...
-
bioRxiv - Cancer Biology 2021Quote: ... 15ng/mL recombinant human TNF (BioLegend #570104) and 1μM Caspase-8 Inhibitor Z-IETD-FMK (R&D Systems #FMK007 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human recombinant TNF was purchased from BioLegend Inc (San Diego ...
-
bioRxiv - Bioengineering 2022Quote: ... 100 IU/mL recombinant human IL-2 (Proleukin, Prometheus Laboratories) and 5 ng/mL recombinant human IL-7 (BioLegend) at 37C ...
-
bioRxiv - Immunology 2022Quote: ... PBMC derived T cells were stimulated for five days at 37°C with 1μg/mL anti-CD3 and anti-CD28 and 10ng/mL of recombinant human IL-2 and recombinant human IL-12p70 (BioLegend). On day four of stimulation ...
-
bioRxiv - Immunology 2021Quote: ... and 5ng/ml recombinant human G-CSF (BioLegend). The cells were then incubated for 16 hours at 37°C and 5%CO2 ...
-
bioRxiv - Immunology 2020Quote: ... Human recombinant IFN-α2 was from Biolegend (592704) and hybrid IFNα-B/D was from Novartis (CGP35269).
-
bioRxiv - Developmental Biology 2020Quote: ... 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-basic (FGF-2 ...
-
bioRxiv - Biophysics 2023Quote: ... and 2 μg/mL recombinant human CCL2 (Biolegend).
-
bioRxiv - Bioengineering 2023Quote: ... 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-2 (Peprotech) ...
-
bioRxiv - Cell Biology 2023Quote: ... 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-2 (Peprotech) ...
-
bioRxiv - Immunology 2024Quote: ... plus 20 ng/mL recombinant human BAFF (Biolegend) for 3 days ...
-
bioRxiv - Immunology 2023Quote: ... Skin immune cells were subsequently added to each fibroblasts-placed well and co-cultured in the presence of 20 ng/ml human IL-2 recombinant and 20 ng/ml human IL-15 recombinant (BioLegend, 570304) in 24 well plates (Ratio of 50:1 immune cell-to-fibroblast) ...
-
bioRxiv - Immunology 2019Quote: ... and 5 ng/mL recombinant human IL-15 (Biolegend). Before use ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 100 IU/mL recombinant human IL-2 (Biolegend) in RPMI media supplemented with 10% FBS ...
-
bioRxiv - Immunology 2021Quote: ... recombinant PE anti-human/mouse TLR2 (clone QA16A01; Biolegend), FITC anti-mouse CD14 (clone Sa14-2 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 20 ng/mL recombinant human thrombopoietin (hTPO) (BioLegend #597402), DNase (100 μg/mL final concentration) ...
-
bioRxiv - Immunology 2020Quote: ... and 50 ng/ml recombinant human M-CSF (BioLegend #574806) for 6 days to obtain monocytes derived macrophages ...
-
bioRxiv - Immunology 2021Quote: ... 5ng/ml or 50ng/ml recombinant human G-CSF (BioLegend) or mouse G-CSF (BioLegend) ...
-
bioRxiv - Microbiology 2022Quote: ... and FITC anti-human/mouse Granzyme B recombinant antibody (Biolegend). Samples were analyzed on the CytoFLEX LX flow cytometer (Beckman Coulter).
-
bioRxiv - Cancer Biology 2022Quote: ... Human and mouse recombinant IFNα/β/γ(all from Biolegend) were used at a concentration of 100ng/ml.
-
bioRxiv - Cancer Biology 2023Quote: ... the tumor organoids were treated with the immune checkpoint inhibitor Nivolumab (Selleckchem, Cat#A2002) and the Ultra-LEAF Purified Human IgG4 Isotype Control Recombinant Antibody (Biolegend, Cat#403701) at a concentration of 10 μg/mL ...
-
bioRxiv - Cancer Biology 2020Quote: Apoptosis was analyzed with an APC Annexin V Apoptosis Detection Kit (BioLegend) following the manufacturer’s protocol ...
-
bioRxiv - Immunology 2021Quote: Recombinant human ARG1 was obtained from Biolegend (San Diego, CA, USA), recombinant murine Arg1 was obtained from Cloud-Clone Corp. ...
-
bioRxiv - Immunology 2021Quote: ... and mouse recombinant PE anti-human/mouse TLR2 (clone QA16A01; Biolegend) were used.
-
bioRxiv - Immunology 2022Quote: ... and recombinant human transforming growth factor beta-1 (TGF-β1; Biolegend) were used at final concentrations of 10 ng/mL ...
-
bioRxiv - Immunology 2023Quote: ... and 1 U/mL of recombinant human IL-2 (BioLegend, #589102) in 200 μL of complete culture medium (see above for media components) ...
-
bioRxiv - Immunology 2023Quote: ... were coated with 1.54 μg/mL human recombinant VCAM-1 (Biolegend) and/or 1.14 μg/mL human recombinant ICAM-1 (R&D system ...
-
bioRxiv - Bioengineering 2023Quote: ... and 500 IU/ml of recombinant human IL-2 (Biolegend, 589104). Stimulated T cells were co-transduced via spinoculation at 931xg ...
-
bioRxiv - Cell Biology 2023Quote: ... HeLa cells were treated with TNF-α recombinant human protein (Biolegend) at a concentration of 75 ng/ml for 24 h in combination with cycloheximide (CHX ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with 1000 U/ml of human recombinant IFN-γ (BioLegend), 20 ng/ml of EGF (Sigma ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 5 % human AB serum (Gemini Bio) and 30 U / mL recombinant human IL-2 (BioLegend) [9] ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 5 % human AB serum (Gemini Bio) and 30 U / mL recombinant human IL-2 (BioLegend). The viability of NALM6-GL cells was then assessed by adding 150 ug / mL D-Luciferin (PerkinElmer ...
-
bioRxiv - Cancer Biology 2019Quote: ... and apoptosis (Annexin V, Biolegend) were assessed and differences between the PHF19 KD cells and control group were analyzed.
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... a final concentration of 5ng/ml of recombinant human TGFβ1 (BioLegend, #580702) was added to the culture media and treated for 24~48 hours ...
-
bioRxiv - Immunology 2022Quote: ... 100ng/ml of recombinant human (rh) IL-8 (Biolegend, San Diego, CA) were added to the apical side of the enteroid monolayers (76) ...
-
bioRxiv - Microbiology 2022Quote: ... in the presence of 50 ng/mL recombinant human M-CSF (Biolegend) for 7 days ...
-
bioRxiv - Cancer Biology 2020Quote: ... in DMEM/F12 supplemented with human recombinant EGF (20 ng/mL, BioLegend), bFGF (20 ng/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... CAR-NK cells were loaded with human recombinant PD-L1- Fc (Biolegend) or ErBb2-Fc fusion proteins (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... and 200 ng/mL recombinant human B cell-activating factor (BAFF, BioLegend).
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/mL human recombinant IL-3 (BioLegend, San Diego, CA, USA) and antibiotics ...
-
bioRxiv - Microbiology 2023Quote: ... in the presence of 50 ng/mL recombinant human M-CSF (Biolegend) for 7 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant human NRG1 was acquired from BioLegend (San Diego, CA, Cat. 551904). High-throughput drug screening assays were used with compounds sourced as indicated in Suppl ...